{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:29:52Z","timestamp":1787671792894,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"15","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Am Acad Orthop Surg","JAAOS"],"published-print":{"date-parts":[[2026,8,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>The mortality risk of patients with peripheral artery disease (PAD) undergoing upper extremity amputation (UEA) remains poorly understood. The aim of this study was to clarify the mortality risk associated with upper extremity amputation in patients with PAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The TriNetX database was retrospectively queried to identify patients with PAD who did or did not undergo UEA, using International Classification of Diseases, 10th Revision, and Current Procedural Terminology codes. Patients were divided into two cohorts: PAD with UEA and PAD without UEA. Propensity score matching was conducted on a 1:1 ratio based on age, sex, body mass index, diabetes, and other comorbidities. Subgroup analyses were conducted based on level of amputation. Kaplan-Meier survival analyses, along with hazard ratios (HRs) and 95% confidence intervals (CIs), were used to assess mortality at 1, 5, and 10 years after UEA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 1,802,975 patients with PAD were identified (1,862 with UEA; 1,801,113 without UEA). Each cohort included 1,862 patients after propensity score matching. Patients who underwent UEA had higher mortality rates at 1 year (24.1% vs. 14.1%), 5 years (54.3% vs. 36.6%), and 10 years (72.5% vs. 54.8%). UEA was associated with increased mortality risk at all time points: 1 year (HR 1.767, 95% CI, 1.500 to 2.081), 5 years (HR 1.739, 95% CI, 1.544 to 1.958), and 10 years (HR 1.705, 95% CI, 1.524 to 1.908). Long-term survival was poor across both digit-level and forearm-level amputation groups, with no statistically significant differences in mortality risk over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>These findings demonstrate an increased mortality risk among patients with PAD who undergo UEA compared with those who do not. Given the high prevalence of diabetes and vascular disease in the United States, these results underscore the importance of early recognition, patient education, and implementation of preventive strategies to reduce disease progression and the potential need for amputation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5435\/jaaos-d-25-01167","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:04:24Z","timestamp":1775646264000},"page":"e2126-e2132","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mortality Risk of Upper Extremity Amputation in Patients With Peripheral Artery Disease"],"prefix":"10.5435","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3661-314X","authenticated-orcid":false,"given":"Seong-Won","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5295-7662","authenticated-orcid":false,"given":"Nicholas C.","family":"Bank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Perle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Megan M.","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid W.","family":"Draeger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"R1-20260729","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/ATVBAHA.120.314595","article-title":"Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease","volume":"40","author":"Barnes","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R2-20260729","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/CIR.0000000000001153","article-title":"Health disparities in peripheral artery disease: A scientific statement from the American heart association","volume":"148","author":"Allison","year":"2023","journal-title":"Circulation"},{"key":"R3-20260729","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.avsg.2016.12.015","article-title":"A meta-analysis of long-term mortality and associated risk factors following lower extremity amputation","volume":"42","author":"Stern","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"R4-20260729","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.jvs.2020.07.086","article-title":"A meta-analysis of mortality after minor amputation among patients with diabetes and\/or peripheral vascular disease","volume":"72","author":"Yammine","year":"2020","journal-title":"J Vasc Surg"},{"key":"R5-20260729","doi-asserted-by":"crossref","first-page":"344","DOI":"10.5152\/j.aott.2021.21100","article-title":"Five-year mortality rate for patients with diabetic hand gangrene who undergo upper extremity amputation","volume":"55","author":"Choi","year":"2021","journal-title":"Acta Orthop Traumatol Turc"},{"key":"R6-20260729","doi-asserted-by":"crossref","first-page":"35320","DOI":"10.52965\/001c.35320","article-title":"Necrotizing fasciitis of the upper extremity\u2014A review","volume":"14","author":"Ditsios","year":"2022","journal-title":"Orthop Rev (Pavia)"},{"key":"R7-20260729","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2147\/VHRM.S440408","article-title":"Anatomical distribution patterns of peripheral arterial disease in the upper extremities according to patient characteristics: A retrospective cohort study","volume":"19","author":"Al-Sharydah","year":"2023","journal-title":"Vasc Health Risk Manag"},{"key":"R8-20260729","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0733-8651(02)00068-1","article-title":"Upper extremity arterial disease","volume":"20","author":"Greenfield","year":"2002","journal-title":"Cardiol Clin"},{"key":"R11-20260729","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.atherosclerosis.2018.05.033","article-title":"Update on peripheral artery disease: Epidemiology and evidence-based facts","volume":"275","author":"Shu","year":"2018","journal-title":"Atherosclerosis"},{"key":"R12-20260729","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1161\/CIRCRESAHA.121.318535","article-title":"Epidemiology of peripheral artery disease and polyvascular disease","volume":"128","author":"Aday","year":"2021","journal-title":"Circ Res"},{"key":"R13-20260729","doi-asserted-by":"crossref","first-page":"101082","DOI":"10.1016\/j.cpcardiol.2021.101082","article-title":"Peripheral artery disease: A comprehensive updated review","volume":"47","author":"Shamaki","year":"2022","journal-title":"Curr Probl Cardiol"},{"key":"R14-20260729","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/ATVBAHA.119.312859","article-title":"Microvascular disease increases amputation in patients with peripheral artery disease","volume":"40","author":"Behroozian","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R15-20260729","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/j.jvs.2023.01.200","article-title":"Updated estimates for the burden of chronic limb-threatening ischemia in the medicare population","volume":"77","author":"Kwong","year":"2023","journal-title":"J Vasc Surg"},{"key":"R16-20260729","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ejvs.2021.01.005","article-title":"Outcomes of conservative treatment in patients with chronic limb threatening ischaemia: A systematic review and meta-analysis","volume":"62","author":"van Reijen","year":"2021","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"R17-20260729","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/17531934211042720","article-title":"Clinical factors and mortality rates for nontraumatic upper extremity amputations","volume":"47","author":"Ting","year":"2022","journal-title":"J Hand Surg Eur Vol"},{"key":"R18-20260729","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jhsa.2023.01.014","article-title":"Predictors of mortality and revision following digital amputation for infection and necrosis","volume":"48","author":"Apel","year":"2023","journal-title":"J Hand Surg Am"},{"key":"R19-20260729","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1558944716628499","article-title":"Nonoperative management of acute upper limb ischemia","volume":"11","author":"Wong","year":"2016","journal-title":"Hand (N Y)"},{"key":"R20-20260729","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhsa.2014.12.036","article-title":"Five-year mortality for patients with end-stage renal disease who undergo upper extremity amputation","volume":"40","author":"Stone","year":"2015","journal-title":"J Hand Surg Am"},{"key":"R21-20260729","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/EDE.0000000000000864","article-title":"Web site and R package for computing E-values","volume":"29","author":"Mathur","year":"2018","journal-title":"Epidemiology"},{"key":"R22-20260729","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: Introducing the E-Value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"R23-20260729","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: Guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"R24-20260729","doi-asserted-by":"crossref","first-page":"e006399","DOI":"10.1161\/CIRCOUTCOMES.119.006399","article-title":"Incidence and factors associated with major amputation in patients with peripheral artery disease: Insights from the EUCLID trial","volume":"13","author":"Long","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R25-20260729","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.avsg.2024.04.007","article-title":"Risk factors for mortality and promoting factors for ambulation after major lower limb amputation for end-stage arterial disease: A multicenter study","volume":"106","author":"Decraemer","year":"2024","journal-title":"Ann Vasc Surg"},{"key":"R26-20260729","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/ATVBAHA.119.312142","article-title":"Evidence-based medical management of peripheral artery disease","volume":"40","author":"Bevan","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R27-20260729","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/jamia\/ocab217","article-title":"Synergies between centralized and federated approaches to data quality: A report from the national COVID cohort collaborative","volume":"29","author":"Pfaff","year":"2022","journal-title":"J Am Med Inform Assoc"},{"key":"R28-20260729","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.amjsurg.2013.01.019","article-title":"Factors affecting healing and survival after finger amputations in patients with digital artery occlusive disease","volume":"205","author":"Landry","year":"2013","journal-title":"Am J Surg"},{"key":"R29-20260729","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ejvs.2018.06.003","article-title":"Editor's choice\u2014Impact of comorbidity, medication, and gender on amputation rate following revascularisation for chronic limb threatening ischaemia","volume":"56","author":"Baubeta Fridh","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"}],"container-title":["Journal of the American Academy of Orthopaedic Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:51:16Z","timestamp":1787669476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.5435\/JAAOS-D-25-01167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":27,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5435\/jaaos-d-25-01167","relation":{},"ISSN":["1067-151X","1940-5480"],"issn-type":[{"value":"1067-151X","type":"print"},{"value":"1940-5480","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"assertion":[{"value":"2025-09-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}